27.70

2.12% -0.60

After Hours: 27.70

Biolife Solutions Inc (BLFS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Biolife Solutions Inc stock is traded at $27.70, with a volume of 244.18K. It is down -2.12% in the last 24 hours and up +5.44% over the past month. BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Previous Close:

$28.30

Open:

$28.68

24h Volume:

244.18K

Relative Volume:

0.68

Market Cap:

$1.28B

Revenue:

$126.12M

Net Income/Loss:

$-73.45M

P/E Ratio:

-16.89

EPS:

-1.64

Net Cash Flow:

$-3.91M

1W Performance:

-0.50%

1M Performance:

+5.44%

6M Performance:

+15.22%

1Y Performance:

+59.65%

1-Day Range:

$27.51

$29.55

1-Week Range:

$27.24

$29.55

52-Week Range:

$14.50

$29.55

Biolife Solutions Inc Stock (BLFS) Company Profile

Name

Biolife Solutions Inc

Sector

Healthcare (1174)

Industry

Medical Instruments & Supplies (60)

Phone

(425) 401-1400

Address

3303 MONTE VILLA PARKWAY, BOTHELL, WA

Employee

414

Twitter

@biolifesol

Next Earnings Date

2024-11-12

Latest SEC Filings

BLFS's Discussions on Twitter

Compare BLFS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BLFS Biolife Solutions Inc	27.70	1.28B	126.12M	-73.45M	-3.91M	-1.64
ISRG Intuitive Surgical Inc	580.18	206.65B	8.35B	2.32B	586.00M	6.41
BDX Becton Dickinson Co	248.49	68.23B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	92.32	45.66B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	257.65	37.85B	4.81B	1.11B	1.35B	7.55
WST West Pharmaceutical Services Inc	343.91	24.95B	2.88B	499.60M	321.60M	6.74

Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-30-24	Initiated	H.C. Wainwright	Buy
Apr-04-24	Initiated	Jefferies	Buy
Jul-11-23	Initiated	Craig Hallum	Buy
Apr-25-22	Upgrade	Oppenheimer	Perform → Outperform
Oct-19-21	Initiated	B. Riley Securities	Buy
Oct-15-21	Resumed	Cowen	Outperform
May-14-21	Downgrade	The Benchmark Company	Buy → Hold
Mar-23-21	Upgrade	The Benchmark Company	Hold → Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Sep-22-20	Downgrade	Oppenheimer	Outperform → Perform
Sep-18-20	Initiated	Cowen	Outperform
Aug-11-20	Downgrade	The Benchmark Company	Buy → Hold
Jul-08-20	Reiterated	Maxim Group	Buy
Feb-24-20	Initiated	Lake Street	Buy
Feb-19-20	Initiated	The Benchmark Company	Buy
Feb-06-20	Resumed	B. Riley FBR	Buy
Jan-08-20	Initiated	Stephens	Overweight
Nov-21-19	Initiated	Oppenheimer	Outperform
Jul-22-19	Initiated	H.C. Wainwright	Buy
Nov-10-17	Reiterated	Maxim Group	Buy
Sep-19-17	Reiterated	Maxim Group	Buy
Jul-05-17	Upgrade	Janney	Neutral → Buy
Mar-10-17	Reiterated	Maxim Group	Buy
Jan-19-17	Initiated	Maxim Group	Buy

View All

Biolife Solutions Inc Stock (BLFS) Latest News

12:01 PM

Breakeven On The Horizon For BioLife Solutions, Inc. (NASDAQ:BLFS) - Yahoo Finance

12:01 PM

Jan 29, 2025